Drug intelligence / Profile preview

Clyraguard

Development stage
Unknown
Lead developer
Clyra Medical Technologies
Modality
Small Molecules
Administration
Topical
01

Overview

Clyraguard is a topical hospital-grade disinfectant spray developed by Clyra Medical Technologies for decontamination of personal protective equipment, especially face masks and coverings, to reduce cross-contamination risk from pathogens including SARS-CoV-2. The product is based on a proprietary copper-iodine small molecule mineral-based formulation derived from Clyra Medical's wound care technology and is designed to deliver broad-spectrum antimicrobial activity against viruses, bacteria, and fungi. It is described as alcohol-free, non-toxic, non-irritating, safe for skin contact, and capable of being sprayed directly onto masks while worn, functioning through direct microbicidal disinfection rather than a conventional receptor-targeted pharmacologic mechanism.

Brand names
Clyraguard
Other names
Clyraguard disinfectant spray

Beyond the preview

Go deeper on Clyraguard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clyraguard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call